Get updates to this list
You’re signing up to all partnering opportunity alerts for:
Please check your inbox
Thank you for verifying your email. We have sent you a confirmation email containing a 6 digit verification code to complete your subscription
You've successfully created a subscription
The search results below each have a summary which you may find useful
in determining if the opportunity is what you’re looking for.
Financial workflows in clinical trials involve several parties in various countries, tax and currency regions. All parties
involved have to deal with many manual tasks, diverse data sources and non-standardized... more
A French clinical research team has developed an innovative treatment for paediatric epileptic seizures coming from a vitamin-sensitive effect. This research team is represented by a Technology Transfer Office... more
A French clinical research team has developped an innovative paediatric treatment for autistic disorders coming from a specific enzym deficiency. The team is represented by a Technology Transfer Office (TTO) which... more
A Swedish SME, active in the area of pharmaceutical technology, has developed a unique platform, including software, for high quality predictions of human clinical ADME/PK (Absorption, Distribution, Metabolism,... more
prevention, care, technical assistance and training of health professionals.
The French organisation has a strong expertise in clinical research and evaluation directly in the field: in geriatrics institutions... more
adverse impacts, including those due to human factor error (e.g., delays, falls, treatment interruption), as well as allowing a correct planning and execution of this assistive clinical process, while reducing... more
The French company is a pre-clinical biotech company with a strong expertise in the fild of monogenetic disorders designing and developing miniaturised and automated in vitro cellular and phenotypic assays based... more
The product is in pre-clinical stage of development. In order to submit the application for phase 1 trial, the following steps have to be performed: (i) generation of a stable antibody producing... more
24/7 that allow having a clear image of the exact ongoing condition. Although some systems are available for use in clinical settings, there is not yet an option for parents to monitor signs reliably at home.... more
An East of England company has developed a genomic platform to improve cancer treatment outcomes through advanced genetic screening technology. It aims at assisting both clinical oncologists and the researchers... more
call for project SC1-BHC-06-2020: Digital diagnostics – developing tools for supporting clinical decisions by integrating various diagnostic data.
The Commission considers that proposals requesting a contribution... more
The Italian company offers a full range of histology and cytology tests for oncology. Stemming from the clinical experience the molecular tests are based on the choice of the most important genes involved in the... more
high in vivo activity against osteosarcoma xenografts in mice. The ADC has a good safety profile in treated animals.
The product is in pre-clinical stage of development. In order to submit the application for... more
of cancer and other complex diseases with an important genetic background. However, the in vivo delivery of oligonucleotides (OGN) has precluded the clinical use of gene-based therapies mainly due to its vulnerability... more
through vectorization and transgene engineering.
Additionally, the company has state-of-the-art technologies and expertise to evaluate the immunological responses to viral vectors in samples from preclinical models and clinical... more
numerous caspase-1 inhibitors have been synthesized, no inhibitor has passed the clinical trial, probably because of the covalent mechanism of action and the consequent unwanted off-target interactions.
The research... more
propensity to hemorrhagic episodes.
The current diagnosis is clinical, but the diagnosis is often delayed due to the gradual onset of symptoms. Thus, having a clinical suspicion,... more
This wound dressing technology has completed in vitro biocompatibility studies with good results. A clinical trial has been lined up to generate the data required for CE marking. The UK SME is looking... more
) orphan disease space—the company’s therapeutic focus.
The company’s pipeline consists of clinical-stage assets for Huntington’s disease and Adrenoleukodystrophy, as well as preclinical-stage assets for Adrenomyeloneuropathy,... more
pressing need for innovative treatments.
Based on preclinical studies on vascular smooth muscle cells, isolated organ studies and animal models, the low molecular weight clinical candidate of the Swiss biotech... more